Radient Pharma (RXPC) Approves 1-to-25 Reverse Split
Tweet
Share
E-mail
Radient Pharmaceuticals Corporation (OTCBB: RXPC), reports its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012.
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Holcim to acquire Fermacell from James Hardie for EUR 840M
- Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate News, Stock SplitsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
